Our thanks to Tutter and Tryz for posting that extremely important PR on the board. Today's PR goes to show once again that CEO Bob Schneiderman is systematically and logically pursuing the aim of expanding Scrips' commitment to the compounding pharmacy business. Twelve more states will now be covered and Scrips America knows where it is headed. In addition, the prospect of other revenue streams contributing more by the end of this year will increase the impact of this progress for those who pay close attention to revenues. As Celtics has often pointed out, as soon as the company becomes cash-flow positive, SCRC will acquire greater kudos and all-round credibility.